Mucovert-CR Tablet
Marketer
Raymedica Pharmaceuticals
Salt Composition
Ambroxol (75mg)
Overview Mucovert-CR Tablet
Respitar-CR tablets effectively manage respiratory conditions characterized by excessive mucus production. This medication thins and liquefies mucus in the nasal passages, trachea, and lungs, facilitating expectoration. Respitar-CR should be administered with food, ideally at the same time each day for optimal efficacy. Dosage and frequency are determined by the specific condition being treated and prescribed by your physician to effectively alleviate symptoms. Prolonged use exceeding 14 days requires medical consultation. Commonly reported side effects include nausea, vomiting, and gastrointestinal discomfort. Consult your doctor regarding persistent or concerning side effects. Alcohol consumption during treatment is generally discouraged. Prior to commencing treatment, inform your physician of any pre-existing liver, kidney, or stomach ailments, and provide a complete list of all medications currently being taken, as interactions may influence the drug's effectiveness or mechanism. Pregnant or breastfeeding individuals should seek medical advice before using Respitar-CR.
Primary Ingredients of Mucovert-CR Tablet
No text provided to rephrase.
Uses of Mucovert-CR Tablet
Managing respiratory conditions characterized by thick mucus.
Major Benefits of Mucovert-CR Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Mucovert-CR Tablet with a meal.
Common Side effects of Mucovert-CR Tablet:
- Vomiting
- Nausea
- Upset stomach
How to use Mucovert-CR Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Mucovert-CR Tablets should be administered with food.
How Mucovert-CR Tablet works:
Mucolytic tablets, such as Mucovert-CR, facilitate the expectoration of respiratory mucus. They achieve this by reducing the viscosity of phlegm in the nasal passages, trachea, and lungs.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Mucovert-CR Tablet may pose unknown risks. Physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
The use of Mucovert-CR Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Mucovert-CR Tablet use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
The effect of Mucovert-CR Tablet on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneyCAUTION
Patients with severe renal impairment should exercise caution when using Mucovert-CR Tablets. Dosage modification for Mucovert-CR Tablets may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should use Mucovert-CR Tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Mucovert-CR Tablet :
Omit any missed Mucovert-CR Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Mucovert-CR Tablet
| Label | Value |
|---|---|
| Chemical Type | N-Methylbenzylamine derivative |
| Developing Habits | No. |
| Treatment Category | Breathing |
| Active Class | Expectorants |

